Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · Real-Time Price · USD

38.02

-0.91 (-2.34%)

At close: Oct 2, 2026, 4:00 PM EDT

37.58

-0.44 (-1.16%)

After-hours: Oct 2, 2026, 7:32 PM EDT

Xenon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,682	3,463	2,989	3,503	2,466	1,643
Market Cap Growth	22.06%	15.89%	-14.68%	42.03%	50.06%	196.62%
Enterprise Value	2,443	2,917	2,195	2,875	1,721	1,397
Last Close Price	38.02	44.82	39.20	46.06	39.43	31.24

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	21.65	21.65	21.65	21.65	21.65
PS Ratio	-	461.80	-	-	261.41	89.14
PB Ratio	2.96	5.95	3.96	3.78	3.42	2.99
P/TBV Ratio	2.96	5.95	3.96	3.78	3.42	2.99
PEG Ratio	-	2.51	2.51	2.51	2.51	2.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	388.87	-	-	182.44	75.77

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Net Debt / Equity Ratio	-1.00	-0.99	-0.99	-0.99	-0.98	-0.99
Net Debt / EBITDA Ratio	2.82	1.56	2.69	4.34	5.56	6.96
Net Debt / FCF Ratio	3.66	2.07	4.04	5.87	6.84	7.60
Asset Turnover	-	0.01	-	-	0.01	0.05
Quick Ratio	20.71	13.17	17.66	23.43	26.12	38.72
Current Ratio	21.02	13.42	17.85	23.65	26.44	39.03
Return on Equity (ROE)	-43.61%	-51.76%	-27.85%	-22.12%	-19.72%	-21.87%
Return on Assets (ROA)	-28.02%	-32.58%	-19.80%	-15.57%	-12.17%	-12.97%
Return on Capital Employed (ROCE)	-35.30%	-63.10%	-36.60%	-22.80%	-17.70%	-14.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-11.11%	-9.99%	-7.84%	-5.21%	-5.08%	-4.80%
FCF Yield	-9.19%	-8.08%	-6.17%	-4.47%	-4.21%	-4.35%
Buyback Yield / Dilution	-10.31%	-1.75%	-16.45%	-10.48%	-38.77%	-21.09%

SEC Filings: 10-K · 10-Q